INVEST in FibroBiologics – Our Reg CF Offering is Now Open!

FOR SCIENTISTS ONLY: New articles added frequently.

Leveraging Fibroblast Technology

Our Product Pipeline

Our Product Pipeline

FibroBiologics has been a pioneer in regenerative medicine for over 2 years and holds over 150+ patents.

CybroCell™

FDA IND Clearance

CYMS101

Stimulates Remyelination

Stimulates Endogenous Neural Stem Cells

CYW628

Accelerate Wound Healing

Recruit Stem Cells for Tissue Remodeling

Early Phase Discovery Projects

CYTER915

Restore Thymus Function

Suppress Impact of Aging on the Immune System

TBC190

T cell Expansion

Stressed Fibroblasts for Dendritic Cell Maturation

Our Product Pipeline

FibroBiologics has been a pioneer in regenerative medicine for over 2 years and holds over 150+ patents.

CybroCell™

FDA IND Clearance

CYMS101

Stimulates Remyelination

Stimulates Endogenous Neural Stem Cells

CYW628

Accelerate Wound Healing

Recruit Stem Cells for Tissue Remodeling

Early Phase Discovery Projects
CYTER915

Restore Thymus Function

Suppress Impact of Aging on the Immune System

TBC190

T cell Expansion

Stressed Fibroblasts for Dendritic Cell Maturation

Our Product Pipeline

FibroBiologics has been a pioneer in regenerative medicine for over 2 years and holds over 150+ patents.

CybroCell™

FDA IND Clearance

CYMS101

Stimulates Remyelination

Stimulates Endogenous Neural Stem Cells

CYW628

Accelerate Wound Healing

Recruit Stem Cells for Tissue Remodeling

Early Phase Discovery Projects
CYTER915

Restore Thymus Function

Suppress Impact of Aging on the Immune System

TBC190

T cell Expansion

Stressed Fibroblasts for Dendritic Cell Maturation

“The lab is a quiet temple for individual persistence.”

–Walter Isaacson
Codebreakers